More Than 115 Presentations and Posters Feature PacBio SMRT Sequencing to Decipher Complex Plant and Animal Genomes at Annual PAG Conference
Thursday, January 12, 2017
to economically and societally important livestock like cattle, goat, and pig, more than 60 new plant and animal genome assemblies generated with PacBio data will be presented at this year’s conference.
“Each year at PAG, we are delighted to see the increasing adoption of SMRT Sequencing and the number of new species benefiting from the highly accurate, uniform long-read data provided by our systems,” said
PacBio will host a workshop in the afternoon of January 16 with speakers from the company and prominent researchers from diverse fields. Topics will cover both conservation genomics and agrigenomics, as well as the fight against Zika and other mosquito vector-based diseases. Dr.
seeing strong growth in agbio, and growing adoption in fields outside of agriculture, such as a number of new projects in conservation biology. Dr.
Director of the
Other PacBio activities include a
About Pacific Biosciences
analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and is the only DNA sequencing technology that provides the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future availability, market adoption, uses, quality or performance of, or benefits of using, products or technologies, and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, changes in circumstances and other factors that are, in some cases, beyond Pacific Biosciences’ control and could cause actual
results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Factors that could materially affect actual results can be found in Pacific Biosciences’ most recent filings with the Securities and Exchange Commission, including Pacific Biosciences’ most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption “Risk Factors.”
Pacific Biosciences undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.
Nicole Litchfield415.793.6468 firstname.lastname@example.org Investors: Trevin Rard650.521.8450 email@example.com
News Provided by Acquire Media